Goldman Sachs’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-62,608
Closed -$1.37M 6610
2017
Q3
$1.37M Buy
+62,608
New +$1.41M ﹤0.01% 4310

Other funds holding SBRA

Goldman Sachs's SBRA Position: Q2 2026 in Review

Goldman Sachs reduced its Sabra Healthcare REIT (SBRA) stake by 7.9% in Q2 2026, selling an estimated $5.84M and leaving 3,439,531 shares worth $67.1M. The position accounts for 0.01% of the portfolio, ranked #1554.

Goldman Sachs first reported a position in SBRA in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.7M in Q1 2022. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Goldman Sachs held 3,439,531 shares of Sabra Healthcare REIT worth $67.1M as of Q2 2026.
  • Goldman Sachs sold 294,410 Sabra Healthcare REIT shares in Q2 2026, an estimated $5.84M.
  • Sabra Healthcare REIT made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1554 holding.
  • Goldman Sachs first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Sabra Healthcare REIT position peaked at $81.7M in Q1 2022.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.